A 12-month prospective study to evaluate the efficacy of using the treat-and-extend regimen with intravitreal aflibercept as a Second-Line Treatment for Diabetic Macular Oedema (the TADI Study)

PURPOSE: To evaluate the efficacy of intravitreal aflibercept as a second-line therapy in eyes with persistent diabetic macular oedema (DMO) despite receiving initial bevacizumab treatment. METHODS: A prospective multicentre study was conducted in nine academic clinics in Israel. Starting from the f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eye (Lond)
Hauptverfasser: Tiosano, Liran, Ehrlich, Rita, Barak, Yoreh, Katz, Haya, Pokroy, Russell, Jaouni, Tarek, Levy, Jaime, Hanhart, Joel, Segal, Ori, Shulman, Shiri, Goldstein, Michaella, Chowers, Itay
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8027790/
https://ncbi.nlm.nih.gov/pubmed/32350452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41433-020-0901-5
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge